Adams' team of 35 scientists spent two years tinkering with dosages to reduce toxic side effects, settling on twice-weekly injections that slowed tumor growth in mice but didn't kill them.
According to the researchers, 20 percent of those taking either high dosages or several of the drugs at once died in a two-year period, an alarmingly high fatality rate.